Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug1160 | Data collection Wiki | 0.50 |
| drug1776 | Hydroxychloroquine (HCQ) Wiki | 0.45 |
| drug2512 | Nasopharyngeal swab Wiki | 0.35 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| D003141 | Communicable Diseases NIH | 0.07 |
| D007239 | Infection NIH | 0.05 |
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
The investigators hypothesize that detection of SARS-CoV2 on saliva samples will increase the performance of the screening program compared to the reference strategy (RT-PCR on a nasopharyngeal swab).
Description: RT-PCR on nasopharyngeal is considered as gold standard
Measure: Positivity of RT-PCR on nasopharyngeal swab for the SARS-CoV-2 virus Time: At diagnosisDescription: Number of samples tested in a day for each test
Measure: Practicability to samples Time: At diagnosisDescription: Quantity of premises required for each test
Measure: Practicability to premises Time: At diagnosisDescription: Feasibly Reading and interpretation For each test
Measure: Practicability to interpretation Time: At diagnosisDescription: Render times for each test
Measure: Practicability to render time Time: At diagnosisDescription: Research of IgG by ELISA and RDT
Measure: IgG Antibody detection in saliva Time: At diagnosisDescription: Research of IgM by ELISA and RDT
Measure: IgM Antibody detection in saliva Time: At diagnosisDescription: Research of IgA by ELISA and RDT
Measure: IgA Antibody detection in saliva Time: At diagnosisDescription: Evaluation by questionnaire of the patient tolerance of the salivary self-sampling compared to the nasopharyngeal swab (questions are about pain, discomfort, speed of performance)
Measure: Patient tolerance of the salivary self-sampling Time: At diagnosisDescription: Evaluation by questionnaire of the operator tolerance of the salivary self-sampling compared to the nasopharyngeal swab (questions is about pain, discomfort, speed of performance)
Measure: Operator tolerance of the salivary self-sampling Time: At diagnosisDescription: Including sampling, transport, technique (consumables, reagents, machine), human resources
Measure: Cost of each approach Time: At diagnosisAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports